OPDIVO Trademark

Trademark Overview

On Friday, October 26, 2012, a trademark application was filed for OPDIVO with the United States Patent and Trademark Office. The USPTO has given the OPDIVO trademark a serial number of 85764349. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, June 4, 2024. This trademark is owned by Bristol-Myers Squibb Company. The OPDIVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [ inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]
opdivo

General Information

Serial Number85764349
Word MarkOPDIVO
Filing DateFriday, October 26, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, June 4, 2024
Registration Number4548457
Registration DateTuesday, June 10, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, Column 2, lines 5-7, "obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke," is deleted, And, In the statement, Column 2, lines 7-11, "inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies" is deleted.
Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [ inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 1, 2012
Primary Code005
First Use Anywhere DateFriday, February 21, 2014
First Use In Commerce DateFriday, February 21, 2014

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Thursday, November 1, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 31, 2012NEW APPLICATION ENTERED
Monday, February 25, 2013ASSIGNED TO EXAMINER
Wednesday, April 3, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 25, 2013NON-FINAL ACTION WRITTEN
Monday, February 25, 2013NON-FINAL ACTION E-MAILED
Monday, February 25, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 2, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 2, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 13, 2013ASSIGNED TO LIE
Thursday, May 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 12, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, February 12, 2014SOU EXTENSION 1 FILED
Sunday, March 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 3, 2014SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 11, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, March 11, 2014USE AMENDMENT FILED
Thursday, March 20, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, April 28, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 2, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, May 3, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 10, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016TEAS SECTION 7 REQUEST RECEIVED
Monday, May 23, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 24, 2016AMENDMENT UNDER SECTION 7 - PROCESSED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 10, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, June 10, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 23, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 23, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 23, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 10, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 4, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 4, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, June 4, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, June 4, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

opdivo diseases pharmaceutical human anti preparations disorders organ solid auto immune